Current Status of Reimbursement Decisions for Orphan Drugs or Cancer Drugs and Implementation for Access Schemes in Korea
Abstract
Authors
Y. Kim Y. Na E. Yim J. Kim M.Y. You
Y. Kim Y. Na E. Yim J. Kim M.Y. You
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now